Global Anal and Colorectal Cancer Market Size, Status and Forecast 2019-2025

SKU ID :QYR-14461540 | Published Date: 19-Jul-2019 | No. of pages: 105
Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer.
Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market growth.
In 2018, the global Anal and Colorectal Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anal and Colorectal Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anal and Colorectal Cancer development in United States, Europe and China.

The key players covered in this study
Abbott Diagnostics
Advaxis
Alere
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck

Market segment by Type, the product can be split into
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy

Market segment by Application, split into
Hospitals
Ambulatory surgery centers
Cancer research centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anal and Colorectal Cancer status, future forecast, growth opportunity, key market and key players.
To present the Anal and Colorectal Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anal and Colorectal Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients